Literature DB >> 10860537

Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A(2) homologue from Bothrops neuwiedi pauloensis venom.

A M Soares1, R Guerra-Sá, C R Borja-Oliveira, V M Rodrigues, L Rodrigues-Simioni, V Rodrigues, M R Fontes, B Lomonte, J M Gutiérrez, J R Giglio.   

Abstract

BnSP-7, a Lys49 myotoxic phospholipase A(2) homologue from Bothrops neuwiedi pauloensis venom, was structurally and functionally characterized. Several biological activities were assayed and compared with those of the chemically modified toxin involving specific amino acid residues. The cDNA produced from the total RNA by RT-PCR contained approximately 400 bp which codified its 121 amino acid residues with a calculated pI and molecular weight of 8.9 and 13,727, respectively. Its amino acid sequence showed strong similarities with several Lys49 phospholipase A(2) homologues from other Bothrops sp. venoms. By affinity chromatography and gel diffusion, it was demonstrated that heparin formed a complex with BnSP-7, held at least in part by electrostatic interactions. BnSP-7 displayed bactericidal activity and promoted the blockage of the neuromuscular contraction of the chick biventer cervicis muscle. In addition to its in vivo myotoxic and edema-inducing activity, it disrupted artificial membranes. Both BnSP-7 and the crude venom released creatine kinase from the mouse gastrocnemius muscle and induced the development of a dose-dependent edema. His, Tyr, and Lys residues of the toxin were chemically modified by 4-bromophenacyl bromide (BPB), 2-nitrobenzenesulfonyl fluoride (NBSF), and acetic anhydride (AA), respectively. Cleavage of its N-terminal octapeptide was achieved with cyanogen bromide (CNBr). The bactericidal action of BnSP-7 on Escherichia coli was almost completely abolished by acetylation or cleavage of the N-terminal octapeptide. The neuromuscular effect induced by BnSP-7 was completely inhibited by heparin, BPB, acetylation, and CNBr treatment. The creatine kinase releasing and edema-inducing effects were partially inhibited by heparin or modification by BPB and almost completely abolished by acetylation or cleavage of the N-terminal octapeptide. The rupture of liposomes by BnSP-7 and crude venom was dose and temperature dependent. Incubation of BnSP-7 with EDTA did not change this effect, suggesting a Ca(2+)-independent membrane lytic activity. BnSP-7 cross-reacted with antibodies raised against B. moojeni (MjTX-II), B. jararacussu (BthTX-I), and B. asper (Basp-II) myotoxins as well as against the C-terminal peptide (residues 115-129) from Basp-II. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860537     DOI: 10.1006/abbi.2000.1790

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  26 in total

1.  Crystallization and preliminary X-ray diffraction analysis of a myotoxic Lys49-PLA2 from Bothrops jararacussu venom complexed with p-bromophenacyl bromide.

Authors:  D P Marchi-Salvador; C A H Fernandes; S F Amui; A M Soares; M R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-05-31

2.  Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor.

Authors:  Fatah Chérifi; Abdelkader Namane; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

3.  Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.

Authors:  Xingding Zhou; Tien-Chye Tan; S Valiyaveettil; Mei Lin Go; R Manjunatha Kini; Adrian Velazquez-Campoy; J Sivaraman
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

4.  Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis.

Authors:  Richard J Ward; Lucimara Chioato; Arthur H C de Oliveira; Roberto Ruller; Juliana M Sá
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

5.  Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2.

Authors:  Carlos Santamaría; Silda Larios; Steve Quirós; Javier Pizarro-Cerda; Jean-Pierre Gorvel; Bruno Lomonte; Edgardo Moreno
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Structural characterization and neuromuscular activity of a new Lys49 phospholipase A(2) homologous (Bp-12) isolated from Bothrops pauloensis snake venom.

Authors:  Priscila Randazzo-Moura; L A Ponce-Soto; Léa Rodrigues-Simioni; Sérgio Marangoni
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

7.  Isolation and pharmacological characterization of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus).

Authors:  Janith C Wickramaratna; Bryan G Fry; Marie-Isabel Aguilar; R Manjunatha Kini; Wayne C Hodgson
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom.

Authors:  Patrícia G Roberto; Simone Kashima; Silvana Marcussi; José O Pereira; Spartaco Astolfi-Filho; Auro Nomizo; José R Giglio; Marcos R M Fontes; Andreimar M Soares; Suzelei C França
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

9.  Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Shao-Heng He
Journal:  BMC Immunol       Date:  2009-04-28       Impact factor: 3.615

10.  Chemical modifications of PhTX-I myotoxin from Porthidium hyoprora snake venom: effects on structural, enzymatic, and pharmacological properties.

Authors:  Salomón Huancahuire-Vega; Daniel H A Corrêa; Luciana M Hollanda; Marcelo Lancellotti; Carlos H I Ramos; Luis Alberto Ponce-Soto; Sergio Marangoni
Journal:  Biomed Res Int       Date:  2012-12-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.